Abstract
A regulatory role for protein kinase C (PKC) and eicosanoids has been implicated in the control of breast cancer cell growth and function. Here we report on the effects of the two PKC agonists 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and bryostatin 1 on arachidonic acid metabolism, prostaglandin E2 (PGE2) production, and growth in MDA MB 231 human breast cancer cells. TPA caused a dose-dependent increase in PGE2 production which was maximal at 100 nM and which was blocked in the presence of an equimolar concentration of bryostatin 1. Bryostatin 1 alone had no effect on PGE2 synthesis. Both TPA and bryostatin 1 stimulated arachidonic acid release and reduced fatty acid incorporation into phosphatidylinositol, their combined effect being less than additive in co-incubation. Interleukin-1β (IL-1β) induced a tenfold and twofold synergistic increase in PGE2 production in the presence of TPA (10 nM) and bryostatin 1 (10 nM) respectively. Bryostatin 1 caused a dose-dependent inhibition of the phorbol ester-potentiated IL-1β response. Treatment of MDA MB 231 cells for 4 days with TPA (10 nM) or bryostatin 1 (10 nM) inhibited cell growth by 74% and 20% respectively. Co-treatment with both PKC agonists reversed the anti-proliferative effect of TPA to that seen with bryostatin 1 alone. In contrast the anti-proliferative action of ceramide, another PKC modulator, was unaffected in the presence of bryostatin 1. TPA also induced morphological changes in MDA MB 231 cells which were prevented by co-treatment with bryostatin 1. This study further supports a regulatory role for PKC in the control of eicosanoid synthesis and growth in human breast cancer cells. Although the findings are consistent with bryostatin 1 acting as an antagonist/weak agonist in relation to TPA action, the mechanistic basis for this differential action of TPA and bryostatin 1 is uncertain.
Similar content being viewed by others
References
O'Brien CA, Vogel VG, Singletary SE, Ward NE: Elevated levels of protein kinase C expression in human breast tumor biopsies relative to normal tissue. Cancer Res 49: 3215-3217, 1989
Darbon J-M, Valette A, Bayard F: Phorbol esters inhibit the proliferation of MCF-7 cells: possible implications of protein kinase C. Biochem Pharmacol 35: 2683-2686, 1986
Valette A, Gas N, Jozan S, Roubinet F, Dupont MA, Bayard F: Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res 47: 1615-1620, 1987
Lee CSL, Koga M, Sutherland RL: Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF-7 breast cancer cells. Biochem Biophys Res Commun 162: 415-421, 1989
Patel KV, Schrey MP: Evidence for a role for protein kinase C in the modulation of bombesin-activated cellular signal124 ling in human breast cancer cells. Mol Cell Endocrinol 85: 215-225, 1992
Hughes R, Timmermans P, Schrey MP: Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1??and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function. Int J Cancer 67: 684-689, 1996
Berkow RL, Kraft AS: Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem Biophys Res Commun 131: 1109-1115, 1985
Dell'Aquila ML, Herald CL, Pettit GR, Blumberg PM: Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells. Cancer Res 48: 3702-3708, 1988
Gschwendt M, Fürstenberger G, Rose-John S, Rogers M, Pettit GR, Herald CL, Marks F: Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivoand in vitro.Carcinogenesis (Lond.) 9: 555-562, 1988
Hocevar BA, Fields AP: Selective translocation of ?II protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem 266: 28-33, 1991
Schrey MP, Patel KV: Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Brit J Cancer 72: 1412-1419, 1995
Karmali RA, Welt S, Thaler HT, Lefevre F: Prostaglandins in breast cancer. Relationship to disease stage and hormone status. Brit J Cancer 48: 689-696, 1983
Schrey MP, Patel KV: Role of regulatory peptides in the control of breast cancer cell growth and function. Endocrine-Related Cancer 1(3): 41-70, 1994
Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE: Differential effects of bryostatin 1and phorbol ester on human breast cancer cell lines. Cancer Res 52: 1278-1283, 1992
Schrey MP, Rubin RP: Characterization of a calcium-mediated activation of arachidonic acid turnover in adrenal phospholipids by corticotropin. J Biol Chem 254: 11234-11241, 1979
Kelly RW, Deam S, Cameron MJ, Seamark RF: Measurement by radio-immunoassay of prostaglandins as their methyl oximes. Prostaglandins Leukotrienes Essent Fatty Acids 24: 1-14, 1986
Olivera A, Buckley NE, Spiegel S: Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J Biol Chem 267: 26121-26127, 1992
Aksamit TR, Monick MM, Hunninghake GW: Protein kinase C modulates the amount of IL-1 receptor mRNA in human lung fibroblasts. J Immunol 151: 284-290, 1993
Parker J, Waite M, Pettit GR, Daniel LW: Stimulation of arachidonic acid release and prostaglandin synthesis by bryostatin 1. Carcinogenesis 9: 1471-1474, 1988
Nutt JE, Harris AL, Lunec J: Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-?1 genes in breast tumour cells. Brit J Cancer 64: 671-676, 1991
Lewin NE, Dell'Aquila ML, Pettit GR, Blumberg PM, Warren BS: Binding of [3H] bryostatin 4 to protein kinase C. Biochem Pharmacol 43: 2007-2014, 1992
Stanwell C, Gescher A, Bradshaw TD, Pettit GR: The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Int J Cancer 56: 585-592, 1994
Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM: Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Mol Pharmacol 46: 840-850, 1994
Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva MY, Obeid LM, Hannun YA: Role of ceramide in cell cycle arrest. J Biol Chem 270: 2047-2052, 1995
Jones MJ, Murray AW: Evidence that ceramide selectively inhibits protein kinase C-??translocation and modulates bradykinin activation of phospholipase D. J Biol Chem 270: 5007-5013, 1995
Rights and permissions
About this article
Cite this article
Boorne, A., Donnelly, N. & Schrey, M. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells. Breast Cancer Res Treat 48, 117–124 (1998). https://doi.org/10.1023/A:1005985832647
Issue Date:
DOI: https://doi.org/10.1023/A:1005985832647